
The real-world findings support the long-term benefits of continuous treatment

ALS is a progressive neurodegenerative disease that affects the motor neurons of the brain and spinal cord

Parkinson’s disease affects over six million people globally

The partnership will provide financial support and strengthen early detection and intervention efforts

Alessio Ciulli has been appointed as Chair of the board

More than seven million people in the US are affected by the neurodegenerative disease

An estimated 13 million people in the US will be living with Alzheimer’s disease by 2050

The company is planning to initiate phase 3 studies of trontinemab in early AD this year

Planning is currently underway for a placebo-controlled trial of the candidate

More than ten million people worldwide are living with the neurodegenerative disorder

It is hoped that the test could be available for widespread UK use in the coming years

A phase 2 trial of the drug is expected to launch in the third quarter of this year